Figure 1From: The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia Experimental protocol. PGE 2 was administered in two different doses (high dose group 200 μg/mouse, and low dose group 100 μg/mouse) and phases (recovery period and during DSS treatment). Control mice were given the same volume of PBS. AOM and DSS (2.5%) were administered as shown. Mice were sacrificed on day 56.Back to article page